EC
MEDP icon

Enhancing Capital’s Medpace MEDP Stock Holding History

Enhancing Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$702K Hold
1,462
– – 0.52% 46
2025
Q4 		$821K Sell
1,462
-84
-5% -$47.7K 0.59% 45
2025
Q3 		$795K Buy
1,546
+64
+4% +$27.9K 0.58% 48
2025
Q2 		$465K Sell
1,482
-1
-0.1% -$300 0.35% 69
2025
Q1 		$452K Buy
1,483
+49
+3% +$16.5K 0.36% 70
2024
Q4 		$476K Buy
+1,434
New +$486K 0.38% 66

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Enhancing Capital's MEDP Position: Q1 2026 in Review

Enhancing Capital held its Medpace (MEDP) position steady in Q1 2026 at 1,462 shares worth $702K. The position accounts for 0.52% of the portfolio, ranked #46.

Enhancing Capital first reported a position in MEDP in Q4 2024 and has held it in 6 quarters since. The position peaked at $821K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Enhancing Capital held 1,462 shares of Medpace worth $702K as of Q1 2026.
  • Enhancing Capital left its Medpace share count unchanged in Q1 2026.
  • Medpace made up 0.52% of Enhancing Capital's portfolio in Q1 2026, its #46 holding.
  • Enhancing Capital first reported a position in Medpace in Q4 2024 and has held it in 6 quarters since.
  • Enhancing Capital's Medpace position peaked at $821K in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Enhancing Capital's 13F filing for Q1 2026, filed 8 May 2026.